Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish third quarter 2025 financial results on Tuesday, November 4, 2025, after U.S. market close.

About Standard BioTools Inc.

Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary SomaScan, mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook ^® , LinkedIn, and YouTube™.

Limited Use Label License and other terms may apply: standardbio.com/legal/salesterms .
Patent and License Information: standardbio.com/legal/notices .
©2025 Standard BioTools Inc. All rights reserved.

Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.

Investor Contact:
ir@standardbio.com

News Provided by GlobeNewswire via QuoteMedia

Standard BioTools LAB NGS:LAB biotech investing

LAB

Pinnacle Discovers More High-Grade Polymetallic Mineralization at El Potrero with Silver Assays up to 1,159 grams per tonne Underscoring District Scale Potential

(TheNewswire) VANCOUVER, BRITISH COLUMBIA TheNewswire - April 20, 2026 (TSXV: PINN,OTC:PSGCF, OTC: PSGCF, Frankfurt: P9J) Pinnacle Silver and Gold Corp. ("Pinnacle" or the "Company") is pleased to announce that continued ground follow up on shafts, adits and prospecting pits interpreted from the... Keep Reading...

NevGold Announces Positive, Consistent Drill Results on Historic Gold Leach Pads Including 0.34% Antimony And 0.41 g/t Au Over 12.5 Meters; Path to Near-Term Antimony Production Continues

Nevgold Corp. ("NevGold" or the "Company") (TSXV:NAU,OTC:NAUFF) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce positive, consistent antimony ("Sb") and gold ("Au") sonic drill results (see Key Highlights and Appendix I - Drillhole Summary Table) from the historic gold leach pads at its... Keep Reading...

NevGold Intercepts 1.11% Antimony Over 6.1 Meters, Within 1.93 g/t AuEq Over 100.6 Meters From Surface; Focus On Maiden Antimony-Gold Mineral Resource Estimate and Near-Term Antimony Production

Nevgold Corp. ("NevGold" or the "Company") (TSXV:NAU,OTC:NAUFF) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce further positive oxide antimony-gold drill results at its Limousine Butte Project (the "Project", "Limo Butte") in Nevada. All holes completed in the 2025 drill program are now... Keep Reading...

Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

Triple ISO Certification Recognition Positions Company as a Standard-Bearer in Clinical Decision Support Quality Infrastructure

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Company"), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced that Seegnal eHealth Ltd., its Israeli operating subsidiary, has been granted the prestigious Gold Mark by the... Keep Reading...

Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Pinnacle Discovers More High-Grade Polymetallic Mineralization at El Potrero with Silver Assays up to 1,159 grams per tonne Underscoring District Scale Potential

Independent Lab Confirms Gold and Silver Recoveries of 89% and 75% Respectively in Sulphides at Palta Dorada

NevGold Announces Positive, Consistent Drill Results on Historic Gold Leach Pads Including 0.34% Antimony And 0.41 g/t Au Over 12.5 Meters; Path to Near-Term Antimony Production Continues

Lahontan Reports Cyanide Recoveries of 81% for Gold and 60% for Silver at West Santa Fe

NevGold Intercepts 1.11% Antimony Over 6.1 Meters, Within 1.93 g/t AuEq Over 100.6 Meters From Surface; Focus On Maiden Antimony-Gold Mineral Resource Estimate and Near-Term Antimony Production

Lexaria Bioscience: Drug Delivery Platform Innovator with Multiple Mainstream Applications

Lexaria Bioscience

Rewriting the Patient Journey: GLP‑1 Drugs and the Rise of Oral Therapies

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

Triple ISO Certification Recognition Positions Company as a Standard-Bearer in Clinical Decision Support Quality Infrastructure

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Latest News

Lexaria Bioscience: Drug Delivery Platform Innovator with Multiple Mainstream Applications

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Interactive Chart

Latest Press Releases

Aterian PLC: Africa-focused Critical Minerals Exploration Company

Results of Meeting

Valeura Charters the Enterprise Drilling Rig

GoldInxs Mining: Early-stage Exposure to Copper-Gold in British Columbia

Related News

Aterian PLC: Africa-focused Critical Minerals Exploration Company

Results of Meeting

Valeura Charters the Enterprise Drilling Rig

GoldInxs Mining: Early-stage Exposure to Copper-Gold in British Columbia

American Uranium Entitlement Offer Update

Trading Halt

Ore Reserves and Mineral Resources Update

TOP STOCKS